Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Cancer Biology & Medicine
|
February 6, 2024
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
Nanhui Chen, Zengjun Wang, Ming Chen, et al.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Asian Journal of Urology
|
March 8, 2018
Prostate cancer in Asia: A collaborative report
Rui Chen, Shancheng Ren, , et al.
Asian Journal of Urology
|
February 19, 2019
Application of fluorescence <i>in situ</i> hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population
Liqun Zhou, Kaiwei Yang, Xuesong Li, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Medcomm
|
July 24, 2023
Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study
Le Qu, Hui Chen, Qi Chen, et al.
World Journal of Urology
|
October 30, 2017
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium
Tianxin Lin, Kaiwen Li, Hao Liu, et al.
Asian Journal of Urology
|
December 22, 2017
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database
Kaiwen Li, Tianxin Lin, , et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Cancer Biology & Medicine
|
February 6, 2024
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
Nanhui Chen, Zengjun Wang, Ming Chen, et al.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Asian Journal of Urology
|
March 8, 2018
Prostate cancer in Asia: A collaborative report
Rui Chen, Shancheng Ren, , et al.
Asian Journal of Urology
|
February 19, 2019
Application of fluorescence <i>in situ</i> hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population
Liqun Zhou, Kaiwei Yang, Xuesong Li, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Medcomm
|
July 24, 2023
Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study
Le Qu, Hui Chen, Qi Chen, et al.
World Journal of Urology
|
October 30, 2017
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium
Tianxin Lin, Kaiwen Li, Hao Liu, et al.
Asian Journal of Urology
|
December 22, 2017
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database
Kaiwen Li, Tianxin Lin, , et al.
Page
of 18